In dextran sulphate sodium (DSS)-induced colitis mice, the most commonly used preclinical IBD model, injected MOTS-c significantly reduced colon shortening and histological damage, lowered pro-inflammatory cytokines and plasma myeloperoxidase, and curbed macrophage and neutrophil activity
Nowhere near freezing temperatures
This review also highlights several limitations
While oral peptide delivery is an active area of research, no oral CJC-1295/Ipamorelin formulation has demonstrated clinical equivalence to injection
Yes every batch ships with a batch-specific COA documenting HPLC purity and mass-spectrometry identity
But for musculoskeletal injuriestendons, ligaments, musclesthe bioavailability of oral BPC 157 to the rest of the body is significantly lower than injectable forms